Gas analysis is a crucial aspect of pharmaceutical quality control, which plays a significant role in ensuring the safety and efficacy of drugs. This article discusses the role of gas analysis in pharmaceutical quality control, including appropriate methods, uses, and recent research studies.
Image Credit: tanewpix289/Shutterstock.com
Pharmaceutical quality control is a critical aspect of drug development and manufacturing. It involves the monitoring and testing of drug products to ensure that they meet the required standards for safety, efficacy, and quality.
The primary objective of gas analysis in pharmaceutical quality control is to identify and quantify any impurities or degradation products that may be present in a drug product. Impurities can arise from various sources, such as the manufacturing process, storage conditions, or packaging materials. Impurities can affect the safety, efficacy, and stability of a drug product and can lead to adverse effects in patients. Therefore, it is essential to detect and quantify these impurities to ensure the quality and safety of the drug product. Several gas analysis techniques can detect impurities at very low levels, providing accurate and reliable data on the purity of the drug product.
Gas analysis is also used to detect residual solvents in drug products. Residual solvents are used in the manufacturing process of some drug products and can remain in the final product. Residual solvents can be toxic and can affect the safety and efficacy of the drug product. In addition to impurities and residual solvents, gas analysis can be used to monitor the stability of drug products over time. Degradation products can form in drug products over time, affecting the safety and efficacy of the drug. Gas analysis can be used to detect and quantify these degradation products, providing valuable information on the stability of the drug product.
Gas Analysis Techniques for Pharmaceutical Quality Control
Gas analysis can be performed using a range of analytical techniques, including gas chromatography (GC), mass spectrometry (MS), Raman spectroscopy, nuclear magnetic resonance (NMR) spectroscopy, and Fourier-transform infrared spectroscopy (FTIR).
GC is one of the most widely used techniques for gas analysis in pharmaceutical quality control. It separates and identifies the individual components of a gas mixture based on their physical and chemical properties. It can also detect and quantify a wide range of impurities, such as residual solvents, volatile organic compounds, and other contaminants. GC is a highly sensitive and specific technique that can detect impurities at very low levels.
MS is another commonly used technique for gas analysis in pharmaceutical quality control. It is a highly sensitive analytical technique that can identify and quantify compounds based on their mass-to-charge ratio. It can detect impurities and degradation products that may not be detectable by other techniques and is particularly useful for identifying unknown impurities or contaminants.
NMR spectroscopy is a powerful analytical technique that has found numerous applications in pharmaceutical quality control. In gas-phase NMR spectroscopy, the gas sample is placed in a cell and subjected to a magnetic field. The nuclei of the gas atoms will then absorb and re-emit electromagnetic radiation at characteristic frequencies, which can be detected and analyzed to obtain information about the gas composition. It is a non-destructive technique that can be used to analyze gases without altering their chemical composition. Secondly, it is highly sensitive and can detect trace amounts of gases, which is important for ensuring the quality and purity of pharmaceutical products.
Recent Studies
In a recent study published in the journal Pharmaceuticals, the authors carried out a phytochemical analysis of S. triquetra (HESt-1) utilizing a gas chromatography method. A novel technique was created to determine preliminary chromatographic fingerprinting. Ursolic acid (UA) and allantoin were extracted and identified using ultra-performance liquid chromatography coupled with mass spectrometry (UPLC-MS) and NMR, respectively. Gas chromatography identified seven metabolites. By using UPLC-MS, the chromatographic fingerprint of three extracts was examined.
The vasorelaxant effects of all extracts were concentration- and endothelium-dependent. The phytochemical profile was first characterized using chromatographic fingerprinting, and the vasorelaxant activity of S. triquetra was assessed in ex vivo rat models. The study indicated that this plant contains significant amounts of UA, a pentacyclic triterpenoid with diverse pharmacological effects.
In another recent study published in the Journal of Ethnopharmacology, the authors provided an overview of the cutting-edge uses of mass spectrometry imaging (MSI) technology for quality assurance, safety assessments, and identification of the toxicity mechanisms of traditional Chinese medicines (TCMs). They used a high throughput method to develop MSI as a novel analytical imaging technology that could identify and picture the metabolic changes of various TCM components in both plants and animals. This method was quicker, more sensitive, label-free, and high throughput than conventional chemical analysis techniques. The reported technique was also used to investigate the therapeutic/toxic mechanisms of TCMs and narrow the focus on potential biomarkers.
In another study published in the Journal of Pharmaceutical and Biomedical Analysis, the authors presented the first full heteronuclear (1H,13C, and 15N) atom-specific assignment of exenatide, a peptide-based anti-diabetic prescription medication. They reported the determination of condensed amide and carbon fingerprint maps using NMR spectroscopy. To further illustrate the distinctness of these maps, the team contrasted the 2D heteronuclear maps of exenatide to [dHis1]-exenatide. They also demonstrated that the distinctions between the amide maps of exenatide and [dHis1]-exenatide were preserved even when pH, temperature, and concentration were intentionally changed.
In conclusion, gas analysis plays a critical role in pharmaceutical quality control, allowing for the detection and identification of impurities, contaminants, and residual solvents in drug products. The use of gas analysis techniques such as GC-MS, gas chromatography, and FTIR can help ensure the safety and efficacy of drugs, ultimately improving patient outcomes. Ongoing research in this field will continue to advance the use of gas analysis in pharmaceutical quality control, leading to safer and more effective drugs for patients.
More from AZoM: What to Know About Exhaust Gas Analysis
References and Further Reading
Aguilar-Guadarrama, A. B., et al. (2022). Chromatographic Techniques and Pharmacological Analysis as a Quality Control Strategy for Serjania triquetra a Traditional Medicinal Plant. Pharmaceuticals, 15(10), 1289. https://doi.org/10.3390/ph15101289
Jiang, H., et al. (2022). Advanced applications of mass spectrometry imaging technology in quality control and safety assessments of traditional Chinese medicines. Journal of Ethnopharmacology, 284, 114760. https://doi.org/10.1016/j.jep.2021.114760
Mishra, S. H., et al. (2021). Facilitated structure verification of the biopharmaceutical peptide exenatide by 2D heteronuclear NMR maps. Journal of Pharmaceutical and Biomedical Analysis, 203, 114136. https://doi.org/10.1016/j.jpba.2021.114136
Disclaimer: The views expressed here are those of the author expressed in their private capacity and do not necessarily represent the views of AZoM.com Limited T/A AZoNetwork the owner and operator of this website. This disclaimer forms part of the Terms and conditions of use of this website.